Insider · CIK 0002080252
Simcere Zaiming, Inc.
Files at NXTC (NextCure, Inc.). First filing Aug 12, 2026, latest Aug 12, 2026.
In brief
Simcere Zaiming, Inc. files SEC Form 4 as insider at NXTC (NextCure, Inc.). Since Aug 12, 2026, Simcere Zaiming, Inc. has reported 0 open-market buys worth $0 and 1 open-market sell worth $185k, the latest filed on Aug 12, 2026.
A track record needs three past buys with six months of prices behind them; Simcere Zaiming, Inc. has 0, so none is measured yet.
The newest scored trade: sold $185k of NXTC on Aug 10, 2026, filed Aug 12, 2026, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $185k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NXTC: NextCure, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | NXTC NextCure, Inc. | SOpen-market sale Common Stockindirect: See Footnotes | -30,000 | $6.16 | $185k | 308,636 | Aug 12, 2026 |
Questions about Simcere Zaiming, Inc.
Answered from the filings on this page, as of the latest one.
Is Simcere Zaiming, Inc. buying or selling?
In the last 12 months Simcere Zaiming, Inc. reported 0 open-market buys worth $0 and 1 open-market sell worth $185k on SEC Form 4; the latest was sold $185k of NXTC on Aug 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Simcere Zaiming, Inc.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Simcere Zaiming, Inc. has 0.
Where does Simcere Zaiming, Inc. file Form 4?
Simcere Zaiming, Inc. has filed Form 4 at NXTC (NextCure, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.